AURALGAN Trademark

Trademark Overview


On Wednesday, April 26, 2023, a trademark application was filed for AURALGAN with the United States Patent and Trademark Office. The USPTO has given the AURALGAN trademark a serial number of 97908361. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, July 8, 2025. This trademark is owned by IPL Therapeutics LLC. The AURALGAN trademark is filed in the Pharmaceutical Products category with the following description:

Ear medication, namely, ear drops
auralgan

General Information


Serial Number97908361
Word MarkAURALGAN
Filing DateWednesday, April 26, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, July 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesEar medication, namely, ear drops

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 24, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIPL Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCommerce City, CO 80022

Trademark Events


Event DateEvent Description
Monday, May 1, 2023NEW APPLICATION ENTERED
Wednesday, May 24, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 24, 2024NON-FINAL ACTION WRITTEN
Wednesday, January 24, 2024NON-FINAL ACTION E-MAILED
Wednesday, January 24, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 28, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 28, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 23, 2024ASSIGNED TO EXAMINER
Thursday, March 28, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 10, 2025ASSIGNED TO EXAMINER
Monday, June 16, 2025ASSIGNED TO EXAMINER
Tuesday, July 8, 2025NON-FINAL ACTION E-MAILED
Tuesday, July 8, 2025NON-FINAL ACTION WRITTEN
Tuesday, July 8, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords


auralgan drops namely medication